ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jamieson, S. W.
Right arrow Articles by Shumway, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jamieson, S. W.
Right arrow Articles by Shumway, N. E.

Ann Thorac Surg 1984;38:554-562
© 1984 The Society of Thoracic Surgeons


Articles

Heart-Lung Transplantation for Irreversible Pulmonary Hypertension

S.W. Jamieson, MB., F.R.C.S.*, E.B. Stinson, M.D., P.E. Oyer, M.D., Ph.D., B.A. Reitz, M.D., J. Baldwin, M.D., D. Modry, M.D., K. Dawkins, M.B., J. Theodore, M.D., S. Hunt, M.D., N.E. Shumway, M.D., Ph.D.

Department of Cardiovascular Surgery, Stanford University Medical Center, Stanford, CA

* Address reprint requests to Dr. Jamieson, Department of Cardiovascular Surgery, Stanford University Medical Center, Stanford, CA 94305

Combined heart and lung transplantation was carried out in 17 patients at Stanford University between March, 1981, and December, 1983. The recipients were between 22 and 45 years old. All patients had end-stage pulmonary hypertension; 10 had Eisenmenger's syndrome and the remaining 7, primary pulmonary hypertension. Five patients died within the first few postoperative weeks. The remainder are well between four weeks and 33 months from operation.

The immunosuppressive protocol has consisted of cyclosporine with an initial course of rabbit antithymocyte globulin. Azathioprine also was given for the first two weeks and then was replaced with prednisone. Rejection, as diagnosed by cardiac biopsy, was treated with high doses of methylprednisolone. Modifications of technique that have developed include the removal of the recipient heart and lungs separately, and preservation of the lungs with a modified Collins' solution instead of a cardioplegic solution.

Rejection occurred in 6 of the 12 survivors. Infections developed in 9 patients, but only one resulted in a fatal outcome (Legionella). Thus, the results of clinical heart-lung transplantation have been considerably superior to clinical efforts in lung transplantation. It is suggested that the combined operation is preferable for the following reasons: (1) all diseased tissue is removed, thus eliminating recurrent infection and ventilation/perfusion disparity; (2) transplantation of the entire heart-lung block preserves coronary–bronchial vascular anastomoses and makes airway dehiscence less likely; and (3) to date, diagnosis of rejection by cardiac biopsy has appeared to be a satisfactory method of diagnosing and treating pulmonary rejection. Cardiopulmonary transplantation represents a viable therapeutic approach for patients with end-stage pulmonary hypertension with or without associated congenital heart disease.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. W. Hirt, A. Haverich, T. Wahlers, H.-J. Schafers, A. Alken, and H.-G. Borst
Predictive criteria for the need of extracorporeal circulation in single-lung transplantation
Ann. Thorac. Surg., October 1, 1992; 54(4): 676 - 680.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
C.-M. Hsieh, G. J. Mishkel, P. F. G. Cardoso, H. Rakowski, S. C. Dunn, J. Butany, R. D. Weisel, G. A. Patterson, and J. D. Cooper
Production and reversibility of right ventricular hypertrophy and right heart failure in dogs
Ann. Thorac. Surg., July 1, 1992; 54(1): 104 - 110.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. W. Hirt, T. Wahlers, M. J. Jurmann, L. Dammenhayn, J. Kemnitz, R. Rohde, and A. Haverich
University of Wisconsin versus modified Euro-Collins solution for lung preservation
Ann. Thorac. Surg., January 1, 1992; 53(1): 74 - 79.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. J. Novick, A. H. Menkis, F. N. McKenzie, K. R. Reid, P. W. Pflugfelder, W. J. Kostuk, and D. Ahmad
The safety of low-dose prednisone before and immediately after heart-lung transplantation
Ann. Thorac. Surg., April 1, 1991; 51(4): 642 - 645.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. P. Griffith, R. L. Hardesty, A. Trento, I. L. Paradis, R. J. Duquesnoy, A. Zeevi, J. H. Dauber, J. S. Dummer, M. E. Thompson, S. Gryzan, et al.
Heart-Lung Transplantation: Lessons Learned and Future Hopes
Ann. Thorac. Surg., January 1, 1987; 43(1): 6 - 16.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. H. Dark, G. A. Patterson, A. N. Al-Jilaihawi, H. Hsu, T. Egan, and J. D. Cooper
Experimental En Bloc Double-Lung Transplantation
Ann. Thorac. Surg., October 1, 1986; 42(4): 394 - 398.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1984 by The Society of Thoracic Surgeons.